May 15 (Reuters)-
Enbio Holdings, Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2025 Mar 31, 2024 Mar 31, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 10.67 9.58 11.73
(+11.4 pct) (+17.9 pct) (+9.9 pct)
Operating 839 mln 815 mln 953 mln
(+3.0 pct) (-39.9 pct) (+13.6 pct)
Recurring 702 mln 1.07 844 mln
(-34.2 pct) (-20.5 pct) (+20.2 pct)
Net
Net 452 mln 708 mln 554 mln
(-36.1 pct) (-12.7 pct) (+22.4 pct)
EPS 55.90 yen 88.85 yen 68.41 yen
Ann Div 9.00 yen 8.00 yen 9.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 9.00 yen 8.00 yen 9.00 yen
NOTE - Enbio Holdings, Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6092.T